Living Donor Liver Transplantation for HBV-/HCV-Related Diseases
Living donor liver transplantation (LDLT) remains a major transplant modality in Japan and accounts for 99% of total liver transplantation. LDLT for adult patients has increased rapidly in the last five years and now occupies a majority. Among 297 adult LDLT patients in Kyoto University Hospital, indications for HBV- or HCV-related diseases account for 38% including cirrhosis combined with hepatocellular carcinoma and fulminant hepatitis. The paper outlines general and rather specific problems relating peritransplant management and results in LDLT for viral diseases.
KeywordsAcute Rejection Live Donor Liver Transplantation Fulminant Hepatic Failure Fulminant Hepatitis Recurrent Hepatitis
Unable to display preview. Download preview PDF.